• LAST PRICE
    27.5000
  • TODAY'S CHANGE (%)
    Trending Down-0.3400 (-1.2213%)
  • Bid / Lots
    14.0000/ 1
  • Ask / Lots
    36.3600/ 1
  • Open / Previous Close
    27.8300 / 27.8400
  • Day Range
    Low 27.2000
    High 27.9200
  • 52 Week Range
    Low 9.5000
    High 41.2900
  • Volume
    70,598
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 27.84
TimeVolumeVTYX
09:32 ET37327.83
09:33 ET10027.48
09:35 ET20027.84
09:39 ET22527.87
09:42 ET10027.73
09:44 ET20027.81
09:46 ET24827.795
09:51 ET30027.82
09:57 ET30027.815
10:02 ET70027.52
10:04 ET10027.505
10:08 ET130527.72
10:09 ET140027.56
10:11 ET60027.49
10:22 ET30027.575
10:24 ET10027.55
10:26 ET40027.51
10:31 ET70027.41
10:33 ET10027.41
10:36 ET20027.44
10:38 ET10027.44
10:40 ET30027.41
10:44 ET10027.445
10:45 ET30027.5
10:47 ET40027.5
10:49 ET20027.495
10:51 ET120027.35
10:54 ET50027.3
10:56 ET54927.2
10:58 ET90227.37
11:00 ET40027.35
11:02 ET10027.32
11:03 ET70027.41
11:05 ET80027.49
11:07 ET10027.5
11:09 ET70027.47
11:12 ET136727.45
11:14 ET51027.4463
11:16 ET10027.48
11:20 ET100027.42
11:23 ET30027.46
11:25 ET20027.45
11:27 ET50027.525
11:34 ET41827.59
11:36 ET10027.72
11:38 ET30027.64
11:41 ET30027.835
11:43 ET10027.845
11:45 ET50027.67
11:48 ET10027.67
11:50 ET10027.73
11:52 ET10027.78
11:54 ET30027.72
11:57 ET50027.68
11:59 ET10027.59
12:03 ET50027.71
12:06 ET40027.62
12:08 ET20027.6
12:12 ET20027.66
12:14 ET10027.58
12:15 ET10027.6
12:17 ET70027.53
12:19 ET10027.48
12:30 ET30027.515
12:32 ET100127.48
12:33 ET30027.475
12:37 ET20027.49
12:39 ET20027.5
12:42 ET60027.51
12:44 ET10027.585
12:48 ET30027.56
12:50 ET82027.635
12:51 ET65627.53
12:53 ET130027.49
12:55 ET177127.52
12:57 ET50027.52
01:00 ET631427.5
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTYX
Ventyx Biosciences Inc
1.6B
-15.4x
---
United StatesDICE
Dice Therapeutics Inc
1.6B
-15.9x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.6B
-10.9x
---
United StatesAGIO
Agios Pharmaceuticals Inc
1.6B
-4.3x
---
United StatesCLDX
Celldex Therapeutics Inc
1.6B
-14.9x
---
United StatesSWTX
SpringWorks Therapeutics Inc
1.5B
-4.6x
---
As of 2022-11-26

Company Information

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with significant unmet need. Its pipeline includes VTX958, VTX002, and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). Its lead product candidate, VTX958, is an oral, selective allosteric tyrosine kinase type 2 (TYK2) inhibitor to address a range of immune-mediated diseases, such as psoriasis, Crohns disease, psoriatic arthritis and lupus. VTX958 is designed to selectively inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms. It is developing VTX002, an oral, selective sphingosine 1 phosphate receptor 1 (S1P1R) modulator for the treatment of ulcerative colitis (UC). Its lead NLRP3 inhibitor product candidate, VTX2735, is designed to treat systemic inflammatory diseases, such as cardiovascular, hepatic, renal and rheumatologic diseases.

Contact Information

Headquarters
662 Encinitas Blvd., Ste. 250, Suite 250ENCINITAS, CA, United States 92024
Phone
858-945-2393
Fax
302-655-5049

Executives

Chairman of the Board
Sheila Gujrathi
President, Chief Medical Officer
William Sandborn
Chief Executive Officer, Founder, Director
Raju Mohan
Chief Financial Officer
Martin Auster
Chief Scientific Officer
John Nuss

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$0.00
Shares Outstanding
56.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.79
Book Value
$5.54
P/E Ratio
-15.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.